Biotechnology IGC Pharma Says Cannabinoid-Based Drug Candidate Provides Fast Relief With Fewer Side Effects For Alzheimer’s-Associated Agitation – IGC Pharma (AMEX:IGC) Read more
Biotechnology UBS Bullish On This Depression Drug Maker, Says Alzheimer’s Agitation Data Is Attractive Catalyst – Axsome Therapeutics (NASDAQ:AXSM) Read more